Lyka Labs Limited (LYKALABS.BO)

INR 110.15

(-0.68%)

EBITDA Summary of Lyka Labs Limited

  • Lyka Labs Limited's latest annual EBITDA in 2023 was 167.58 Million INR , down -21.18% from previous year.
  • Lyka Labs Limited's latest quarterly EBITDA in 2024 Q1 was 37.07 Million INR , up 58.23% from previous quarter.
  • Lyka Labs Limited reported an annual EBITDA of 128.46 Million INR in 2022, down -80.55% from previous year.
  • Lyka Labs Limited reported an annual EBITDA of 1.01 Billion INR in 2021, up 382.99% from previous year.
  • Lyka Labs Limited reported a quarterly EBITDA of 20.28 Million INR for 2023 Q4, down -72.62% from previous quarter.
  • Lyka Labs Limited reported a quarterly EBITDA of 74.06 Million INR for 2023 Q3, up 67.4% from previous quarter.

Annual EBITDA Chart of Lyka Labs Limited (2023 - 2009)

Historical Annual EBITDA of Lyka Labs Limited (2023 - 2009)

Year EBITDA EBITDA Growth
2023 167.58 Million INR -21.18%
2022 128.46 Million INR -80.55%
2021 1.01 Billion INR 382.99%
2020 196.83 Million INR 464.76%
2019 -26.16 Million INR -254.3%
2018 -16.42 Million INR 58.74%
2017 -25.16 Million INR -118.7%
2016 208.7 Million INR 20.53%
2015 284.16 Million INR 1.35%
2014 275.8 Million INR 811.4%
2013 -24.49 Million INR -110.96%
2012 312.17 Million INR 0.0%
2011 - INR -100.0%
2010 252.29 Million INR 27.21%
2009 193.12 Million INR 0.0%

Peer EBITDA Comparison of Lyka Labs Limited

Name EBITDA EBITDA Difference
Alfavision Overseas (India) Limited 10.12 Million INR -1555.363%
Biocon Limited 41.52 Billion INR 99.596%
Blue Jet Healthcare Limited 2.29 Billion INR 92.689%
Concord Biotech Limited 4.65 Billion INR 96.403%
Dishman Carbogen Amcis Limited 3.07 Billion INR 94.544%
FERMENTA BIOTECH LIMITED 262.68 Million INR 36.201%
GENOMIC VALLEY BIOTECH LIMITED 147.4 Thousand INR -113595.201%
Panacea Biotec Limited -200.6 Million INR 183.544%
SAMSRITA LABS LIMITED -2.46 Million INR 6911.315%
Servoteach Industries Limited - INR -Infinity%
SMS Lifesciences India Limited 349.41 Million INR 52.037%
Supriya Lifescience Limited 1.83 Billion INR 90.871%
Syngene International Limited 10.84 Billion INR 98.455%
TAKE Solutions Limited -1.05 Billion INR 115.948%
Titan Biotech Limited 360.29 Million INR 53.486%
Transgene Biotek Limited -4.33 Million INR 3962.388%
Vanta Bioscience Limited 14.19 Million INR -1080.953%